Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

OBJECTIVE: The clinical benefit of ursodeoxycholic acid (UDCA) in primary biliary cholangitis (PBC) has never been reported in absolute measures. The aim of this study was to assess the number needed to treat (NNT) with UDCA to prevent liver transplantation (LT) or death among patients with PBC. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Harms, Maren H, de Veer, Rozanne C, Lammers, Willem J, Corpechot, Christophe, Thorburn, Douglas, Janssen, Harry L A, Lindor, Keith D, Trivedi, Palak J, Hirschfield, Gideon M, Pares, Albert, Floreani, Annarosa, Mayo, Marlyn J, Invernizzi, Pietro, Battezzati, Pier Maria, Nevens, Frederik, Ponsioen, Cyriel Y, Mason, Andrew L, Kowdley, Kris V, Hansen, Bettina E, van Buuren, Henk R, van der Meer, Adriaan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398464/
https://www.ncbi.nlm.nih.gov/pubmed/31843787
http://dx.doi.org/10.1136/gutjnl-2019-319057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398464/
https://www.ncbi.nlm.nih.gov/pubmed/31843787
http://dx.doi.org/10.1136/gutjnl-2019-319057

Ejemplares similares